Bodycote plc is a global provider of thermal processing services, specializing in heat treatment, surface technology, hot isostatic pressing, and metal joining. The company offers classical heat treatments such as nitriding and carburising, alongside proprietary technologies including Powdermet, Kolsterising, and low pressure carburising. Bodycote serves manufacturers across various industries by enhancing the strength, durability, and corrosion resistance of metal components. Its operations span a network of locations worldwide, including facilities in Europe, North America, and Asia. The company provides services to local and international clients, leveraging a global network of metallurgists and engineers to address complex materials challenges. Bodycote’s business segments include precision heat treatment, surface technology, hot isostatic pressing, and metal joining, with specific focus on specialty stainless steel processes.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Specialty Industrial Machinery Homepage bodycote.com
Sector Industrials IR page bodycote.com/investors
Tags
heat treatment, surface technology, hot isostatic pressing, metal joining, nitriding, carburising, powdermet, kolsterising, metallurgy, thermal processing, S3P, Bodycote Kapfenberg, Bodycote Marchtrenk, Bodycote Sint-Niklaas, Bodycote Burlington, Bodycote Kitchener, Bodycote Bromont, Bodycote Changzhou, Bodycote Jinan, Bodycote Kunshan, Bodycote Taicang, Bodycote Brno, Bodycote Prague, Bodycote Krnov, Bodycote Liberec, Bodycote Ejby, Bodycote Tampere, Bodycote Vantaa, Bodycote Pieksamaki, Bodycote Magny-Cours, Bodycote Voreppe, Bodycote Beaugency, Bodycote Gémenos, Bodycote Chanteloup-les-Vignes, Bodycote Villaz, Bodycote Neuilly-en-Thelle, Bodycote Pusignan, Bodycote Cambes, Bodycote Saint-Remy en Mauges, Bodycote Billy Berclau TTH, Bodycote Billy Berclau Induction, Bodycote La Talaudiere, Bodycote Cernay, Bodycote Saint-Nicolas d'Aliermont, Bodycote Conde sur Noireau, Bodycote Amiens, Bodycote Saint-Aubin les Elbeuf, Bodycote Le Subdray, Bodycote La Monnerie Le Montel, Bodycote Lagny Sur Marne, Bodycote Ambazac, Bodycote Serres-Castet, Bodycote Nogent, Bodycote La Talaudiere Ion Implantation, Bodycote Gandrange, Bodycote Haag-Winden, Bodycote Langenselbold, Bodycote Menden, Bodycote Esslingen, Bodycote Wehingen, Bodycote Schmerbach, Bodycote Nürnberg, Bodycote Ebersbach, Bodycote Otterfing, Bodycote Landsberg S3P, Bodycote Karben S3P, Bodycote Hirzenhain, Bodycote Budapest
Press page bodycote.com/resources/press-releases

Metrics

Valuation  
Market cap £ 936.865M
Market cap (USD) $ 1.254B
P/E 16.29
PEG —
P/BV 1.53
P/S 1.27
P/OCF 6.53
P/FCF —
Dividend yield 1.3%
Turnover / mcap —
Returns  
ROE 8.4%
ROI 7.2%
ROIC 8.1%
Profit margin 7.6%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -9.3%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 20.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 17
Quality score -16.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 727.1M 757.1M 802.5M 743.6M 615.8M 598M 719.7M 728.6M 690.2M 690.2M 567.2M 609.1M 619.6M 587.8M 587.8M —
Net profit 55.4M 20.7M 86.8M 74.3M 60M 800K 94M 103.6M 97.3M 97.3M 67M 79.3M 73.1M 67M 67.2M —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price — 5.47 5.85 6.54 6.77 — — — — — — — — — — —
Price performance 12m — -0.06 -0.11 -0.03 — — — — — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (GBP) — 116M 117M 154M 148M 141M 145M
↳ YoY growth +0.7% +32.0% -3.9% -4.8% +2.8%
↳ 5y CAGR +4.6%
Borrowings, current (GBP) — 53.2M 91.7M 70.6M 32.6M 87.4M 800,000
Borrowings, non-current (GBP) — — — — — 84.3M 129M
Lease liabilities (GBP) — 75.6M 64.5M 66M 64.3M 63.5M 60.8M
Cash and deposits (GBP) 20.9M 29.2M 37.9M 36.2M 44.7M 16M 24.4M
Right-of-use assets (GBP) — 69M 57.6M 59.6M 58.5M 56.4M 54.3M
Net debt (borrowings + leases - cash) (GBP) — 99.6M 118M 100M 52.2M 135M 166M
Cash flow detail
Operating cash flow (GBP) — 139M 144M 143M 192M 153M 144M
Purchases of property, plant and equipment (GBP) — -57.8M -45.1M -57.2M -74.1M -70.1M -76.4M
Purchases of intangible assets (GBP) — -2.1M -6.9M -9.8M -8.3M -4.1M -2.1M
Dividends paid (cash effect) (GBP) — -25.1M -49M -38.5M -40.6M -42.9M -40.9M
Share buybacks (cash effect) (GBP) — -500,000 0.00 0.00 -13.2M 0.00 —
Interest paid (cash effect) (GBP) — -5M -5.5M -6.2M -7.2M -9.7M -8.6M
Free cash flow (OCF - PPE - intangibles) (GBP) — 79.2M 92.3M 75.9M 109M 78.4M 65M
Income detail
Total comprehensive income (GBP) — 900,000 48M 134M 58.9M 10.5M 39.5M
Comprehensive income to owners (GBP) — 800,000 48.2M 133M 58.5M 10.1M 39.5M
Reported Mar 25, 2022 Mar 25, 2022 Mar 25, 2022 Apr 4, 2024 Apr 4, 2024 Apr 16, 2026 Apr 16, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Investments in advanced heat treatment and HIP capacity position Bodycote to support the next generation of aerospace manufacturing in the Midwest

  • More than $30 million invested across Bodycote facilities in Fairfield and London, Ohio
  • New Fairfield facility expands vacuum heat treatment and brazing capacity with room for further growth
  • $20 million mega HIP investment at London site significantly increases capacity for high-performance aerospace components

Person in red shirt beside large blue HIP vessel with safety railings in tidy facility; shelves and equipment visible behind.Bodycote, the world’s leading provider of advanced heat treatment and specialist thermal processing services, has invested more than $30 million across two facilities in Ohio, expanding its capacity and capabilities in response to growing demand from aerospace and defense manufacturers in the region.

The investments at Fairfield and London strengthen Bodycote’s position within a rapidly developing aerospace manufacturing cluster. Alongside its established aerospace and defense industry, Ohio is attracting growing investment in areas including advanced air mobility, aircraft electrification and autonomous flight.

Bodycote has invested $12 million in relocating and expanding its former Cincinnati operation into a new facility in Fairfield, increasing vacuum heat treatment and brazing capacity and creating room for further growth. At London, approximately $20 million has been invested in a new large-scale Hot Isostatic Pressing (HIP) vessel that will substantially increase processing capacity for high-volume aerospace applications.

“These investments demonstrate our confidence in the long-term growth of aerospace and defense and in Ohio’s increasingly important role within the industry,” says Heidi McNary, President, Global Aerospace, Defense and Energy at Bodycote. “Ohio has a long-established aerospace heritage, but we are also seeing a new generation of aerospace manufacturing taking shape across the region. These developments are creating new requirements throughout the aerospace supply chain. By investing in capacity and capability today, we are positioning Bodycote close to our customers and ensuring we can continue to support their growth as aerospace technologies and production requirements evolve.”

Bodycote’s relocation to Fairfield places them closer to aerospace manufacturers and suppliers located in cities like Dayton and Columbus. As part of the relocation, Bodycote increased its number of vacuum furnaces, expanding available capacity to process higher volumes and larger components while providing greater production flexibility to support critical customer production schedules.

Two-storey Bodycote commercial building in New Fairfield, Ohio with large glass windows and empty car park under partly cloudy sky.Much of the existing equipment was also comprehensively modernized during the move. Furnaces were upgraded, while new centralized monitoring and control provides enhanced visibility of furnace data. The additional space also creates opportunities to add liquid penetrant inspection, tensile testing and other capabilities over time, enabling multiple processes to be completed under one roof.

Bodycote has also invested in its London, Ohio facility. The site specializes in Hot Isostatic Pressing, a process that uses high temperature and isostatic gas pressure to improve the density, integrity and mechanical properties of critical metal components.

The approximately $20 million investment centers on a new “mega HIP” vessel, together with rapid and jet cooling functionality and high-pressure capability. The equipment will be operational from the beginning of October 2026.

The new vessel will significantly increase throughput at London, enabling Bodycote to process several thousand aerospace components during a single cycle compared with hundreds using its existing smaller vessels. The additional scale will support high-volume jet-engine applications while creating capacity for a broader range of aerospace work.

“The Fairfield and London investments strengthen our ability to support our customers,” adds Antony Funston, Vice President, Operations, HIP & PHT, Midwest at Bodycote. “Aerospace manufacturers need capacity, reliability and increasingly close technical collaboration throughout their supply chains. By expanding our capabilities in Ohio, we can provide that support closer to our customers while creating the capacity to grow alongside them for many years to come.”

https://www.bodycote.com/wp-content/uploads/2025/11/hip-main-image-1a.jpg 1920 1080 jim jim https://secure.gravatar.com/avatar/8a5c38f95c4bcc0d39f13e2d2b6c3a0fb9070dfabbd743f52edf39cb64ee29a5?s=96&d=mm&r=g 22/09/2026 22/09/2026

You might also like

Giving flight-critical parts a second life

06/10/2026

Giving flight-critical parts a second life

Bodycote 2026 Interim Results

28/07/2026

Bodycote 2026 Interim Results

Bodycote expands aerospace and defense capacity across the eastern United States

21/07/2026

Bodycote expands aerospace and defense capacity across the eastern United States

Previous Post

Bodycote 2026 Interim Results

Next Post

Giving flight-critical parts a second life

Why choose Bodycote

Find out how Bodycote can help your business

###### Expertise you can trust

World-class metallurgists, engineers and technicians partner with you directly – combining deep expertise with real, responsive service.

Read More

###### Global scale, local access

Wherever you are, Bodycote connects you to the world’s most advanced thermal processing network.

Read More

###### Superior, lasting performance

Tailored thermal processes that deliver strength, reliability and durability – where it matters most.

Read More

###### Designed for sustainability

Smarter processes, Smaller footprint. Designed to support your sustainability goals – our innovations can cut carbon emissions by up to 60%.

Read More

Why choose Bodycote

Find out how Bodycote can help your business

###### Expertise You Can Trust

World-class metallurgists, engineers and technicians partner with you directly – combining deep expertise with real, responsive service.

Read More

###### Global Scale, Local Access

Wherever you are, Bodycote connects you to the world’s most advanced thermal processing network.

Read More

###### Superior, Lasting Performance

Tailored thermal processes that deliver strength, reliability and durability – where it matters most.

Read More

###### Designed for Sustainability

Smarter processes, Smaller footprint. Designed to support your sustainability goals – our innovations can cut carbon emissions by up to 60%.

Read More

Bodycote 2026 Interim Results Bull 0 Bear 0 Routine

Bodycote’s 2026 interim results are now online at https://www.bodycote.com/investors/

Bodycote’s 2026 Half Year Results presentation will take place on Tuesday 28 July 2026.

A webcast with Jim Fairbairn (Group Chief Executive) and Ben Fidler (Chief Financial Officer) will be held at 8.45am (BST).

View the webcast here.

https://www.bodycote.com/wp-content/uploads/2025/05/Bodycote-solo-white-keyline-1232x368-trans.png 1232 368 jim jim https://secure.gravatar.com/avatar/8a5c38f95c4bcc0d39f13e2d2b6c3a0fb9070dfabbd743f52edf39cb64ee29a5?s=96&d=mm&r=g 28/07/2026 28/07/2026

You might also like

Giving flight-critical parts a second life

06/10/2026

Giving flight-critical parts a second life

Bodycote invests more than $30 million to support Ohio’s growing aerospace sector

22/09/2026

Bodycote invests more than $30 million to support Ohio’s growing aerospace sector

Bodycote expands aerospace and defense capacity across the eastern United States

21/07/2026

Bodycote expands aerospace and defense capacity across the eastern United States

Previous Post

Bodycote expands aerospace and defense capacity across the eastern United States

Next Post

Bodycote invests more than $30 million to support Ohio’s growing aerospace sector

Why choose Bodycote

Find out how Bodycote can help your business

###### Expertise you can trust

World-class metallurgists, engineers and technicians partner with you directly – combining deep expertise with real, responsive service.

Read More

###### Global scale, local access

Wherever you are, Bodycote connects you to the world’s most advanced thermal processing network.

Read More

###### Superior, lasting performance

Tailored thermal processes that deliver strength, reliability and durability – where it matters most.

Read More

###### Designed for sustainability

Smarter processes, Smaller footprint. Designed to support your sustainability goals – our innovations can cut carbon emissions by up to 60%.

Read More

Why choose Bodycote

Find out how Bodycote can help your business

###### Expertise You Can Trust

World-class metallurgists, engineers and technicians partner with you directly – combining deep expertise with real, responsive service.

Read More

###### Global Scale, Local Access

Wherever you are, Bodycote connects you to the world’s most advanced thermal processing network.

Read More

###### Superior, Lasting Performance

Tailored thermal processes that deliver strength, reliability and durability – where it matters most.

Read More

###### Designed for Sustainability

Smarter processes, Smaller footprint. Designed to support your sustainability goals – our innovations can cut carbon emissions by up to 60%.

Read More

Author: Niall Sharma Bull 4 Bear 0 Results

BODYCOTE HY26 RESULTS 28 July 2026

Disclaimer Bodycote plc (the ‘Group’) is providing the following cautionary statement: this presentation has been prepared solely to provide additional information to shareholders to assess the Group’s strategies and the potential for those strategies to succeed. The presentation should not be relied on by any other party or for any other purpose. This presentation contains certain forwardlooking statements. These statements are made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation and such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information.

Bodycote plc Interim Results

2

AGENDA 01 INTRODUCTION 02 HY26 RESULTS 03 STRATEGY UPDATE 04 Q & A

Bodycote plc Interim Results

3

INTRODUCTION JIM FAIRBAIRN Bodycote plc Interim Results

4

01 INTRODUCTION

H1 in line with expectations; FY Outlook unchanged Key highlights:

01

Core organic revenue growth of +9.6% in line with expectations (Group: +6.5%)

02

Growth reflects strong demand in A&D (+24.6%) and IGT; Medical returned to growth

03

Partly offset by continued structural challenges in Automotive (-4.4%)

04

Core margins up 30bps (Group: +110bps) reflecting delivery of Optimise benefits and revenue growth

05

Further strategic progress delivered in H1; exploring options to expand Optimise programme

Bodycote plc Interim Results

5

01 INTRODUCTION

Strong Core growth led by Aerospace & Defence Core organic growth of 9.6% in H1: ▪ Aerospace & Defence up 24.6% organically reflecting strong demand across both OE and AM ▪ Industrial Markets remain fragile with stronger performance in Europe vs North America ▪ Growth partly offset by Automotive (-4.4%), where conditions remain challenging in Western Europe ▪ Energy returned to growth (+4.7%), led by strong IGT demand; Oil & Gas has largely stabilised following 2025 headwinds ▪ Strong growth in Consumer, Medical & Other (+14.8%) driven by Semiconductor demand and return to growth in Medical

H1 2026 Core revenue by end market

Good H1 performance vs soft 1H25 comparator Core growth

Organic revenue growth

10.0%

38%

Aerospace & Defence

24.6%

21%

Industrial Markets

1.3%

20%

Automotive

4.4%

10%

Energy

4.7%

11%

Consumer, Medical & Other

14.8%

Total Core

9.6%

5.0% 3.2% 0.0% -3.5% -5.0%

Bodycote plc Interim Results

9.6%

H1 25

H2 25

H1 26

6

HY RESULTS BEN FIDLER Bodycote plc Interim Results

7

02 HY26 RESULTS

Key highlights Strong topline growth and share buyback effect drove EPS growth of 18.3%

Core organic growth1

Core operating margin

+9.6%

16.2%

Group: +6.5%

+30bps vs H1 25

Cash conversion

Leverage

68%

0.7x

Operating cash flow conversion (H1 25: 68%)

Net Debt / EBITDA 2 (FY 25: 0.6x)

Earnings per share

25.2p H1 25: 21.3p

Shareholder returns

~£45m

Cash returned via dividend and buyback

1 Revenue growth on an organic basis (stated at constant currency, excluding contributions from acquisitions and disposals) 2 Net debt pre-IFRS 16 leases over adjusted EBITDA

Bodycote plc Interim Results

8

02 HY26 RESULTS

Results summary Organic Total Change Change

£m, unless stated

H1 2026

H1 2025

Revenue

372.0

336.6

9.6%

10.5%

Adjusted operating profit

60.4

53.5

11.0%

12.9%

Adjusted operating margin

16.2%

15.9%

381.2

369.0

6.5%

3.3%

Adjusted operating profit

61.0

55.1

12.9%

10.7%

Adjusted operating margin

16.0%

14.9%

+110bps

Adjusted profit before tax

56.6

50.5

12.1%

Adjusted EPS

25.2p

21.3p

18.3%

Interim dividend

7.2p

6.9p

4.3%

CORE1

GROUP Revenue

Core adjusted operating margin +30bps despite variable pay headwind & growth ramp-up costs

+30bps

Group margins +110bps reflecting Optimise benefit as Non-Core revenue reduces

Interim dividend of 7.2p, up 4%

1 Excludes Non-core sites included in the original Optimise programme

Bodycote plc Interim Results

9

02 HY26 RESULTS

Profit growth led by Specialist Technologies ▪ Operating profit increase of 11% in H1 driven by: – Strong topline growth in Specialist Technologies (+16.7%) and Precision Heat Treatment (+6.4%) – Incremental Optimise benefits of c.£2m flowing through the divisions and Central costs – Partly offset by higher variable pay and growth project ramp-up costs, as previously guided Adjusted operating profit (£m) 4.6

2.4

0.4 -1.0

-0.5

Non-Core

Central costs

61.0

55.1

HY 2025

Bodycote plc Interim Results

Specialist Technologies

Precision Heat Treatment

Foreign exchange

HY 2026

10

02 HY26 RESULTS

Creating a better utilised and more efficient Group Optimise enabling reduction in costs alongside revenue growth

More efficient, higher quality 27/31 Optimise sites exited to-date

25% of revenue retained ~4% reduction in headcount ~11% reduction in energy intensity1

GROWTH

EFFICIENCY

Revenue

Labour cost

vs H1 2025

vs H1 2025

1% DOWN

3% UP Organic revenue

Utility cost

vs H1 2025

vs H1 2025

6% UP

2% DOWN

Group operating margins 1 Revenue (£m) per kWh

Bodycote plc Interim Results

110bps UP

11

02 HY26 RESULTS

Specialist Technologies H1 growth of 16.7%, led by Aerospace & Defence

£m

H1 2026

H1 2025

Organic Change

Total Change

Revenue

121.2

104.5

16.7%

16.0%

Adjusted operating profit

31.6

27.2

16.9%

16.2%

Adjusted operating margin

26.1%

26.0%

+10bps

▪ A&D revenue up 37% and now ~50% of Specialist Tech revenue ▪ Two material A&D LTAs renewed with additional volumes ▪ Medical returned to growth; strong IGT (+16.9%) growth in Energy whilst the decline in Oil & Gas moderated as anticipated ▪ Margins grew 10bps: volume growth partly offset by variable pay headwind and growth project ramp-up costs

Revenue (constant currency) 140

H1 2026 Revenue by end market

120 100

Organic revenue growth

80

50%

Aerospace & Defence

37.1%

13%

Industrial Markets

7.0%

7%

Automotive

5.7%

17%

Energy

1.9%

13%

Consumer, Medical & Other

15.7%

Total Specialist Technologies

16.7%

60 40 20

H1 2024

H2 2024

Bodycote plc Interim Results

H1 2025

H2 2025

H1 2026

12

02 HY26 RESULTS

Precision Heat Treatment Good growth across our target end markets

£m

H1 2026

H1 2025

Organic Change

Total Change

Revenue

250.8

232.1

6.4%

8.1%

Adjusted operating profit

37.6

34.9

5.2%

7.7%

Adjusted operating margin

15.0%

15.0%

0bps

▪ Strong Commercial Aerospace growth in the UK and US; Defence up 6.0% led by demand in North America ▪ Modest Industrial Markets growth, benefitting from Optimise revenue transfers; softer demand in North America ▪ Automotive remains challenging, down 4.3% with softness in Western Europe and China ▪ Margins stable: volume growth offset by variable pay headwind and temporary ramp-up costs relating to new A&D investments

Revenue (constant currency) 300

H1 2026 Revenue by end market

250

Organic revenue growth

200 150 100 50

H1 2024

H2 2024

Bodycote plc Interim Results

H1 2025

H2 2025

H1 2026

32%

Aerospace & Defence

16.4%

25%

Industrial Markets

3.6%

26%

Automotive

4.3%

6%

Energy

8.6%

11%

Consumer, Medical & Other

14.3%

Total Precision Heat Treatment

6.4%

13

02 HY26 RESULTS

Cash flow statement Adjusted operating cash flow improved YoY led by profit growth; cash conversion stable £m

H1 2026

H1 2025

Change

Adjusted operating profit

61.0

55.1

+5.9

Depreciation & amortisation

34.4

35.1

-0.7

Other

(1.0)

Adjusted EBITDA

94.4

90.2

+4.2

Net capital expenditure

(33.5)

(38.0)

+4.5

Principal element of lease payments

(6.9)

(6.8)

-0.1

Provisions movement

0.2

(0.1)

+0.3

Net working capital movement

(12.6)

(7.6)

-5.0

Adjusted operating cash flow

41.6

37.7

+3.9

Restructuring

(9.5)

(7.0)

-2.5

Net financing costs

(4.0)

(4.0)

Net tax

(13.6)

(8.7)

-4.9

Free cash flow

14.5

18.0

-3.5

Bodycote plc Interim Results

-1.0

Capex expected to increase in H2 as project spend builds Working capital increase reflects revenue growth and timing effects Operating cash conversion stable at 68% FY26 cash tax expected to be c.£25m

14

02 HY26 RESULTS

Capital allocation Consistent delivery against our capital allocation priorities ▪ Net debt (excluding leases) of £135.2m at period-end; leverage at 0.7x net debt/EBITDA ▪ Capex investment expected to increase in H2 as we continue to support our growth strategy ▪ Acquisition of Spectrum completed in January 2026, increasing our Aerospace & Defence capability in North America ▪ Interim dividend of 7.2p per share, up 4% year-on-year ▪ £80m share buyback programme progressing: c.1.9m shares acquired for VWAP of c.680p (£12.6m spent in H1)

CAPITAL EXPENDITURE

ORDINARY DIVIDENDS

HY 2026:

HY 2026:

£33.5m

Bodycote plc Interim Results

£27.5m

ACQUISITIONS HY 2026:

£5.5m

SHARE BUYBACK HY 2026:

£17.8m

15

02 HY26 RESULTS

Technical guidance Guidance FY 2026

FY 2025

H1 2026

Reported

Reported

Prior

Updated

Revenue impact

£(8.5)m

£1.1m

c.£3m

£(1)-(2)m

Adjusted operating profit impact

£(1.8)m

£0.4m

~£(0.5)m

Non-Core revenue

£55.5m

£9.2m

c.£15m

£12-15m

Capital expenditure

£77m

£33.5m

£80-90m

c.£80m

P&L net finance charge

£9.1m

£4.4m

c.£11m

c.£10m

P&L adjusted tax rate

24.9%

23.5%

c.24.5%

~23.5%

Cash tax

£18.6m

£13.6m

c.£25m

c.£25m

Weighted average share count1

176.8m

171.1m

c.170m

c.170m

Translational foreign exchange

Estimated translational FX impact for FY 2026 based on current FX rates

Other items

Capex increase reflects disciplined growth investment to drive strategy Low level of variable remuneration in 2025; return to normal levels in 2026 Ramp-up costs on new growth projects expected to continue in H2

1 Share count assumes £80m buyback to run until the end of 2027 at current share price

Bodycote plc Interim Results

16

STRATEGY UPDATE JIM FAIRBAIRN Bodycote plc Interim Results

17

03 STRATEGY UPDATE

Executing our strategy at pace Optimise

Entering final phase of site consolidations; exploring potential to expand the programme

Perform

‘Lighthouse’ operational excellence sites now running; remain confident in ~100bps margin improvement from Perform by 2028

Grow

Growing momentum on new contract wins and M&A pipeline building; Spectrum successfully integrated and performing well

Bodycote plc Interim Results

18

03 STRATEGY UPDATE

Optimise

Optimise programme benefits building Programme is on track and delivering expected benefits; exploring potential to expand scope

Cumulative

Sites exited

2025 FY

2026 FY

Total programme

18

29

31 ▪ Programme delivery on-track

In-year

Profit benefit Cumulative

Net cash costs Cumulative

P&L charge

~£4m

~£8m

At least £15m run-rate by mid-2027

£(1)m1

£10-15m

£10-15m

£52.8m

~£60m

~£60m

▪ 27 site exits completed, with 29/31 complete by the end of 2026 ▪ Benefits build further through 2027 as retained revenue ramps-up ▪ Exploring potential options to expand the scope of the programme, focused on more structurally challenged Automotive sites

1 ~£18m gross cash spend, offset by proceeds of £19.3m from disposal of a package of sites in France

Bodycote plc Interim Results

19

03 STRATEGY UPDATE

Perform

Perform: selected ‘Lighthouse’ sites Lighthouses will become regional training hubs to accelerate the Perform roll-out across our >100 sites

Lighthouse 1: US HIP Product Fabrication site

Other Lighthouse sites ▪ Lighthouse 2: EU PHT site

▪ Launched: April 2026

▪ Launched: March 2026

▪ Significant opportunity to improve yield, product flow and inventory management

▪ 4 kaizens conducted ▪ Margin target: + >250bps

▪ Targets: – - 50%TAT 1 – - 75% NPI lead time 2 – + >300bps operating margins

Above: value stream mapping exercise

▪ Lighthouse 3: EU PHT site ▪ Launched: June 2026 ▪ 2 kaizens conducted ▪ Margin target: + >200bps

▪ Progress to-date: – 3 kaizen events (value stream mapping & 5S) – NPI lead time reduced by ~30%

▪ Lighthouse 4: US ST site ▪ Launched: July 2026

1 TAT: Turn-around time 2 NPI lead time: New product introduction lead time

Bodycote plc Interim Results

Above: plant layout post value stream & 5S improvements

▪ 1 kaizen conducted ▪ Margin target: + >175bps

20

03 STRATEGY UPDATE

Improving the quality of our portfolio Continued transition towards higher quality, faster growing end markets FY 2023 Excess capacity in developed markets: Auto & Industrial

Today ▪ Exited 27/31 Non-core sites ▪ Acquired Lake City & Spectrum

Drivers of mix shift Strong underlying growth

▪ Invested in A&D growth projects Organic acceleration & investment

35%

1

48%

1

Targeted further M&A bolt-ons

Potential further consolidations/exits

1% of Group revenue in higher growth end markets

Bodycote plc Interim Results

21

OUTLOOK JIM FAIRBAIRN Bodycote plc Interim Results

22

04 OUTLOOK

H1 in line with expectations; FY Outlook unchanged Outlook: ▪ FY outlook unchanged; mindful of the current geopolitical and macroeconomic environment ▪ Expect to deliver Core organic revenue growth led by A&D, IGT and Medical; partly offset by continued Automotive weakness ▪ Pace of growth expected to moderate in H2 due to tougher prior year comparators ▪ Expect to deliver Group margin improvement supported by growing Optimise benefits, despite variable pay headwind and growth ramp-up costs

▪ Continued deployment of Perform & Grow initiatives to create a higher quality, more resilient and faster growing Bodycote ▪ Remain confident in the delivery of our medium-term financial targets

Bodycote plc Interim Results

23

Q&A Bodycote plc Interim Results

24

APPENDIX

Bodycote plc Interim Results

25

APPENDIX

Non-core Further reduction in Non-core revenue as the Optimise programme progresses HY 2026

HY 2025

Organic Change

Total Change

Revenue

9.2

32.4

-53.2%

-71.6%

Adjusted operating profit

0.6

1.6

-62.5%

Adjusted operating margin

6.5%

4.9%

+160bps

£m

▪ Plan to exit all Non-Core sites as part of the Optimise programme

Revenue (constant currency) H1 2026 Revenue by end market

45

40 35

Organic revenue growth

30

19%

Aerospace & Defence

40.2%

47%

Industrial Markets

44.4%

26%

Automotive

59.2%

10

1%

Energy

92.9%

5

7%

Consumer, Medical & Other

68.5%

Total Non-core

53.2%

25

20 15

H1 2024

H2 2024

Bodycote plc Interim Results

H1 2025

H2 2025

H1 2026

26

APPENDIX

HY 2026 Statutory income statement £m

H1 2026

H1 2025

Revenue

381.2

369.0

Adjusted operating profit

61.0

55.1

Amortisation of acquired intangible assets

(4.8)

(4.8)

Acquisition costs

(0.2)

Exceptional items

(10.4)

(9.1)

Operating profit

45.6

41.2

Net finance charge

(4.4)

(4.6)

Profit before taxation

41.2

36.6

Earnings per share (basic)

18.1p

15.5p

Adjusted earnings per share (basic)

25.2p

21.3p

Bodycote plc Interim Results

27

APPENDIX

HY 2026 Cash flow statement £m

HY 2026

HY 2025

Adjusted EBITDA

94.4

90.2

Net capital expenditure

(33.5)

(38.0)

Principal element of lease payments

(6.9)

(6.8)

Provisions movement

0.2

(0.1)

Net working capital movement

(12.6)

(7.6)

Adjusted operating cash flow

41.6

37.7

Restructuring

(9.5)

(7.0)

Net financing costs

(4.0)

(4.0)

Net tax

(13.6)

(8.7)

Free cash flow

14.5

18.0

Net lease liability additions and disposals

5.0

4.3

Ordinary dividend

(27.5)

(28.8)

Acquisition spend, net

(5.0)

Ordinary shares purchased for share buyback programme

(17.8)

(30.9)

3.4

2.1

Increase in net debt

(27.4)

(35.3)

Opening net debt

(165.5)

(131.8)

2.0

(3.2)

Closing net debt

(190.9)

(170.3)

Lease liabilities

55.7

57.8

(135.2)

(112.5)

Own shares purchased less share-based payments

Foreign exchange movements

Net debt excluding lease liabilities

Bodycote plc Interim Results

28

APPENDIX

Foreign Exchange B/S currency (at closing rates)

HY 2026

HY 2025

EUR

1.17

1.17

USD

1.33

1.37

SEK

12.86

13.06

TRY

61.85

54.53

P&L currency (at average rates)

Annual revenue sensitivity1

Annual profit sensitivity1

HY 2026

HY 2025

% of HY 2026 revenue

EUR

1.14

1.19

30%

~£2.2m

~£0.5m

USD

1.32

1.30

42%

~£3.2m

~£0.7m

SEK

12.50

13.25

6%

~£0.5m

~£0.1m

TRY

58.70

48.87

2%

~£0.1m

~£0.05m

1 Estimated impact of a 1% change in FX rate on annual revenue and adjusted operating profit

Bodycote plc Interim Results

29

APPENDIX

Definitions Term

Definition

Organic measures

At constant currency, and excluding corporate acquisition and disposal activities from the current and comparative periods

Adjusted operating profit

Operating profit before acquisition costs, exceptional items and amortisation of acquired intangibles

Adjusted profit before tax

Profit before tax, acquisition costs, exceptional items and amortisation of acquired intangibles

Adjusted EBITDA

Earnings before interest, tax, depreciation, amortisation, impairment of fixed assets, profit or loss on disposal of property, plant and equipment, exceptional items and acquisition costs

Adjusted operating margin

Adjusted operating profit divided by revenue

Adjusted operating cash flow

Adjusted EBITDA including working capital movements, provisions, capital expenditure and the principal element of lease payments

Free cash flow

Adjusted operating cash flow less restructuring cash flows, finance costs and taxes paid

Free cash flow conversion

Free cash flow as a percentage of adjusted operating profit

Adjusted EPS

Earnings per share excluding acquisition costs, exceptional items and amortisation of acquired intangible assets

RCF

Revolving Credit Facility

Exceptional items

Significant (by virtue of size or incidence) events or transactions including, but not limited to, impairment charges, costs associated with significant restructuring and reorganisation costs and other one-off items

Bodycote plc Interim Results

30

Prompts

Bodycote plc (ticker BOY), listed in United Kingdom.

ETFs Holding Bodycote plc

ETF Weight in ETF Shares Market value As of
DISV 0.14% 595,764 $ 7.256M Nov 12, 2026
DFIS 0.08% 376,709 $ 4.588M Nov 12, 2026
AVDS 0.07% 22,573 $ 272.822K Nov 16, 2026
AVDE 0.02% 276,917 $ 3.347M Nov 16, 2026
AVSD 0.01% 3,830 $ 46.29K Nov 16, 2026